{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:41:55Z","timestamp":1783071715086,"version":"3.54.6"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T00:00:00Z","timestamp":1572652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010578","name":"Deutsche Gesellschaft f\u00fcr Kardiologie-Herz und Kreislaufforschung.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010578","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jaccao.2019.09.008","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T16:36:04Z","timestamp":1576600564000},"page":"196-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Increased Cancer Prevalence in Peripartum Cardiomyopathy"],"prefix":"10.1016","volume":"1","author":[{"given":"Tobias J.","family":"Pfeffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Schlothauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Pietzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Schaufelberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Auber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Ricke-Hoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"List","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Berliner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeska","family":"Abou Moulig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt","family":"Arany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Sliwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6065-9649","authenticated-orcid":false,"given":"Denise","family":"Hilfiker-Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccao.2019.09.008_bib1","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/eurheartj\/ehv009","article-title":"Peripartum cardiomyopathy: current management and future perspectives","volume":"36","author":"Hilfiker-Kleiner","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2019.09.008_bib2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart\u00a0Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy","volume":"12","author":"Sliwa","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jaccao.2019.09.008_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrcardio.2014.37","article-title":"Pathophysiology and epidemiology of peripartum cardiomyopathy","volume":"11","author":"Hilfiker-Kleiner","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jaccao.2019.09.008_bib4","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.jacc.2018.07.085","article-title":"Cardiac outcomes in pregnant women with treated cancer","volume":"72","author":"Liu","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jaccao.2019.09.008_bib5","first-page":"399","article-title":"Peripartum cardiomyopathy occurring in a patient previously treated with doxorubicin","volume":"314","author":"Katz","year":"1997","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jaccao.2019.09.008_bib6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00395-013-0366-9","article-title":"Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy","volume":"108","author":"Haghikia","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jaccao.2019.09.008_bib7","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.117.030816","article-title":"The failing heart stimulates tumor growth by circulating factors","volume":"138","author":"Meijers","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2019.09.008_bib8","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/ejhf.586","article-title":"Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart\u00a0Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy","volume":"18","author":"Bauersachs","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jaccao.2019.09.008_bib9","doi-asserted-by":"crossref","first-page":"e004620","DOI":"10.1161\/CIRCHEARTFAILURE.117.004620","article-title":"Devil in disguise: hints and pitfalls in diagnosis of peripartum cardiomyopathy","volume":"11","author":"Bauersachs","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jaccao.2019.09.008_bib10","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1172\/JCI64365","article-title":"MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy","volume":"123","author":"Halkein","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaccao.2019.09.008_bib11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ejhf.1178","article-title":"Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart\u00a0Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy","volume":"20","author":"Sliwa","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jaccao.2019.09.008_bib12","series-title":"Verbreitung von Krebserkrankungen in Deutschland - Entwicklung der Pr\u00e4valenzen zwischen 1990 und 2010","author":"Bertz","year":"2010"},{"key":"10.1016\/j.jaccao.2019.09.008_bib13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration","volume":"14","author":"Thorvaldsdottir","year":"2013","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.jaccao.2019.09.008_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jaccao.2019.09.008_bib15","doi-asserted-by":"crossref","first-page":"D1018","DOI":"10.1093\/nar\/gky1105","article-title":"Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources","volume":"47","author":"Kohler","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaccao.2019.09.008_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajhg.2018.04.013","article-title":"Comprehensive cancer-predisposition gene testing in an adult multiple primary tumor series shows a broad range of deleterious variants and atypical tumor phenotypes","volume":"103","author":"Whitworth","year":"2018","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaccao.2019.09.008_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jaccao.2019.09.008_bib18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.jaccao.2019.09.008_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.celrep.2018.03.076","article-title":"Genomic and molecular landscape of DNA damage repair deficiency across The Cancer Genome Atlas","volume":"23","author":"Knijnenburg","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaccao.2019.09.008_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.gene.2016.06.031","article-title":"POLD1: central mediator of DNA replication and repair, and implication in cancer and other pathologies","volume":"590","author":"Nicolas","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.jaccao.2019.09.008_bib21","first-page":"372","article-title":"DNA repair goes hip-hop: SMARCA and CHD chromatin remodellers join the break dance","author":"Rother","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.jaccao.2019.09.008_bib22","article-title":"Thioredoxin reductase 2 (Txnrd2) regulates mitochondrial integrity in the progression of age-related heart failure","volume":"4","author":"Yoshioka","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jaccao.2019.09.008_bib23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jns.2014.12.008","article-title":"Diagnostic clues and manifesting carriers in fukutin-related protein (FKRP) limb-girdle muscular dystrophy","volume":"348","author":"Schottlaender","year":"2015","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jaccao.2019.09.008_bib24","doi-asserted-by":"crossref","first-page":"a003095","DOI":"10.1101\/cshperspect.a003095","article-title":"Cadherins as targets for genetic diseases","volume":"2","author":"El-Amraoui","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.jaccao.2019.09.008_bib25","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1038\/s41467-018-06748-3","article-title":"Pregnancy duration and breast cancer risk","volume":"9","author":"Husby","year":"2018","journal-title":"Nature Commun"},{"key":"10.1016\/j.jaccao.2019.09.008_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/M18-1323","article-title":"Breast cancer risk after recent childbirth: a pooled analysis of 15 prospective studies","volume":"170","author":"Nichols","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaccao.2019.09.008_bib27","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ejhf.1165","article-title":"Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge","volume":"20","author":"Ameri","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jaccao.2019.09.008_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju232","article-title":"Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities","volume":"106","author":"Shelburne","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jaccao.2019.09.008_bib29","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2019.09.008_bib30","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/eurheartj\/ehz046","article-title":"Late onset heart failure after childhood chemotherapy","volume":"40","author":"Hilfiker-Kleiner","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2019.09.008_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.118.037934","article-title":"Genetic variants associated with cancer therapy-induced cardiomyopathy","volume":"140","author":"Garcia-Pavia","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2019.09.008_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared genetic predisposition in peripartum and dilated cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaccao.2019.09.008_bib33","unstructured":"Wieser T. Carnitine Palmitoyltransferase II Deficiency. In: Adam MP, Ardinger HH, Pagon RA, et\u00a0al (eds). Seattle, WA: GeneReviews;\u00a01993."},{"key":"10.1016\/j.jaccao.2019.09.008_bib34","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1016\/j.jmb.2013.07.035","article-title":"Mechanistic basis of desmosome-targeted diseases","volume":"425","author":"Al-Jassar","year":"2013","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.jaccao.2019.09.008_bib35","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/humu.23656","article-title":"Current review of TP53 pathogenic germline variants in breast cancer patients outside Li-Fraumeni syndrome","volume":"39","author":"Fortuno","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaccao.2019.09.008_bib36","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1002\/jcp.27464","article-title":"Hereditary breast cancer; genetic penetrance and current status with BRCA","volume":"234","author":"Mahdavi","year":"2019","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jaccao.2019.09.008_bib37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/asheducation-2017.1.242","article-title":"Pediatric leukemia susceptibility disorders: manifestations and management","volume":"2017","author":"McReynolds","year":"2017","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jaccao.2019.09.008_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/13892029113146660012","article-title":"NBN gene polymorphisms and cancer susceptibility: a systemic review","volume":"14","author":"Berardinelli","year":"2013","journal-title":"Curr Genomics"},{"key":"10.1016\/j.jaccao.2019.09.008_bib39","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3892\/or.2013.2541","article-title":"Hereditary breast and ovarian cancer susceptibility genes (review)","volume":"30","author":"Kobayashi","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jaccao.2019.09.008_bib40","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s00432-018-2763-9","article-title":"Multigene panel testing beyond BRCA1\/2 in breast\/ovarian cancer Spanish families and clinical actionability of findings","volume":"144","author":"Bonache","year":"2018","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jaccao.2019.09.008_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/genes8020059","article-title":"An exploratory study to determine whether BRCA1 and BRCA2 mutation carriers have higher risk of cardiac toxicity","volume":"8","author":"Sajjad","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jaccao.2019.09.008_bib42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncomms1601","article-title":"BRCA1 is an essential regulator of heart function and survival following myocardial infarction","volume":"2","author":"Shukla","year":"2011","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaccao.2019.09.008_bib43","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1161\/CIRCULATIONAHA.118.034822","article-title":"DNA\u00a0damage response mediates pressure overload-induced cardiomyocyte hypertrophy","volume":"139","author":"Nakada","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jaccao.2019.09.008_bib44","doi-asserted-by":"crossref","first-page":"9008","DOI":"10.1073\/pnas.1821510116","article-title":"Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy","volume":"116","author":"Hassan","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaccao.2019.09.008_bib45","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/ejhf.780","article-title":"Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart\u00a0Failure Association of the European Society of Cardiology Study Group on PPCM","volume":"19","author":"Sliwa","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jaccao.2019.09.008_bib46","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jacc.2015.06.1309","article-title":"Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (Investigations of Pregnancy-Associated Cardiomyopathy)","volume":"66","author":"McNamara","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266608731930081X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266608731930081X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:52:41Z","timestamp":1762973561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266608731930081X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S266608731930081X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2019.09.008","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Cancer Prevalence in Peripartum Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2019.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}